...
首页> 外文期刊>Archives of Toxicology >RNAi in murine hepatocytes: the agony of choice-a study of the influence of lipid-based transfection reagents on hepatocyte metabolism
【24h】

RNAi in murine hepatocytes: the agony of choice-a study of the influence of lipid-based transfection reagents on hepatocyte metabolism

机译:鼠肝细胞的RNAi:选择的痛苦 - 一种研究脂质转染试剂对肝细胞代谢的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Primary hepatocyte cell cultures are widely used for studying hepatic diseases with alterations in hepatic glucose and lipid metabolism, such as diabetes and non-alcoholic fatty liver disease. Therefore, small interfering RNAs (siRNAs) provide a potent and specific tool to elucidate the signaling pathways and gene functions involved in these pathologies. Although RNA interference (RNAi) in vitro is frequently used in these investigations, the metabolic alterations elucidated by different siRNA delivery strategies have hardly been investigated in transfected hepatocytes. To elucidate the influence of the most commonly used lipid-based transfection reagents on cultured primary hepatocytes, we studied the cytotoxic effects and transfection efficiencies of INTERFERin(A (R)), Lipofectamine(A (R))RNAiMAX, and HiPerFect(A (R)). All of these transfection agents displayed low cytotoxicity (5.6-9.0 +/- A 1.3-3.4 %), normal cell viability, and high transfection efficiency (fold change 0.08-0.13 +/- A 0.03-0.05), and they also favored the satisfactory down-regulation of target gene expression. However, when effects on the metabolome and lipidome were studied, considerable differences were observed among the transfection reagents. Cellular triacylglycerides levels were either up- or down-regulated [maximum fold change: INTERFERin(A (R)) (48 h) 2.55 +/- A 0.34, HiPerFect(A (R)) (24 h) 0.79 +/- A 0.08, Lipofectamine(A (R))RNAiMAX (48 h) 1.48 +/- A 0.21], and mRNA levels of genes associated with lipid metabolism were differentially affected. Likewise, metabolic functions such as amino acid utilization from were perturbed (alanine, arginine, glycine, ornithine, and pyruvate). In conclusion, these findings demonstrate that the choice of non-viral siRNA delivery agent is critical in hepatocytes. This should be remembered, especially if RNA silencing is used for studying hepatic lipid homeostasis and its regulation.
机译:主要肝细胞培养物广泛用于研究具有肝葡萄糖和脂质代谢的改变的肝疾病,例如糖尿病和非酒精脂肪肝疾病。因此,小干扰RNA(siRNA)提供了有效的和特异性工具,以阐明这些病理学中涉及的信令途径和基因函数。虽然在这些研究中经常使用体外RNA干扰(RNAi),但在转染的肝细胞中几乎没有研究不同siRNA递送策略所阐明的代谢改变。为了阐明最常用的基于脂质的转染试剂对培养的原发性肝细胞的影响,我们研究了干扰素的细胞毒性效应和转染效率(A(R)),Lipofectamine(A(R))Rnaimax和HipleFect(A( r))。所有这些转染剂显示出低细胞毒性(5.6-9.0 +/- 1.3-3-3.4%),正常的细胞活力,以及高转染效率(折叠变化0.08-0.13 +/- 0.03-0.05),并且他们也有利于令人满意的靶基因表达下调。然而,当研究了对代谢物和脂质体的影响时,转染试剂中观察到相当大的差异。细胞三酰甘油酯水平上调或下调[最大折叠变化:干扰素(A(R))(48小时)2.55 +/- a 0.34,HIPERFECT(A(R))(24小时)0.79 +/- a 0.08,Lipofectamine(A(R))Rnaimax(48小时)1.48 +/- A 0.21],与脂质代谢相关的基因的mRNA水平差异地影响。同样地,诸如氨基酸利用的代谢功能扰动(丙氨酸,精氨酸,甘氨酸,鸟甘蓝和丙酮酸)。总之,这些研究结果表明,非病毒siRNA递送剂的选择在肝细胞中是至关重要的。应该记住这一点,特别是如果RNA沉默用于研究肝脂质稳态及其调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号